Skip to content
buyWeak cluster of 2

Andrew Arno bought $26k of IMDX

director at Oncocyte Corp. 12,500 shares at an average of $2.11, traded Dec 26, 2024, filed Dec 26, 2024.

Conviction score
31
Value
$26k
12,500 shares
Holdings after
81,554
+18% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet

Score components

  • Role
    Director
    +15
  • Trade size
    $26k at market
    +5
  • Relative to holdings
    Holdings up 18%
    +3
  • Price context
    No price history yet
    0
  • Cluster
    2 insiders buying within 14 days
    +8
  • Repeat buying
    First buy in 90 days
    0
  • Track record
    Too few past buys to judge (0 with prices)
    0

What happened after comparable buys

Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.

Rows in this filing

Every transaction in Form 4 0001493152-24-052168, as filed. Open on EDGAR

DateTransactionSharesPriceValueHoldings afterFiled
Dec 26, 2024POpen-market purchase
Common Stock, no par value
+12,500$2.11$26k81,554Dec 26, 2024

Related signals

Other insiders at Oncocyte Corp and this insider’s other filings.

ScoreCompanyInsiderValueHoldingsFiled
57Moderate
IMDXbuy 2
Oncocyte Corp
Andrea S. James
Chief Financial Officer
$200k
97,561 shares
+182%
50Moderate
IMDXbuy 2
Oncocyte Corp
Broadwood Partners, L.p.
owner
$11M
5,165,695 shares
+83%
30Weak
IMDXbuy 2
Oncocyte Corp
Patrick W Smith
owner
$192k
90,219 shares
+5%
38Weak
IMDXbuy
Oncocyte Corp
Andrea S. James
Chief Financial Officer
$46k
20,000 shares
+59%

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Andrew Arno bought $26k of IMDX | InsiderTell